Protein tyrosine phosphatase inhibitors: a patent review (2002 – 2011)

Author： Sobhia Masilamani Elizabeth Paul Stanly Shinde Ranajit Potluri Mrudula Gundam Venkatesh Kaur Amandeep Haokip Thongtinlal

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.2, 2012-02, pp. : 125-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent discovery and development of protein tyrosine phosphatase inhibitors

By Kim Hwa-Ok Blaskovich Mark A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 871-905

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase inhibitors: a patent review (2007 – 2011)

By de los Ríos Cristóbal

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 853-869

Informa Healthcare

Access to resources Recommend Favorite

p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011)

By Fischer Stefan Koeberle Solveigh C Laufer Stefan A

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1843-1866

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in protein tyrosine phosphatase 1B inhibitors

By Taylor Scott D Hill Bryan

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 199-214

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B)

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-03 ,pp. : 759-782

Bentham Science Publishers

Access to resources Recommend Favorite